BE842969A - Acides et esters thenoylacetiques substitues, leur procede de preparation et leur utilisation comme medicaments hypolipidemiants - Google Patents

Acides et esters thenoylacetiques substitues, leur procede de preparation et leur utilisation comme medicaments hypolipidemiants

Info

Publication number
BE842969A
BE842969A BE167935A BE167935A BE842969A BE 842969 A BE842969 A BE 842969A BE 167935 A BE167935 A BE 167935A BE 167935 A BE167935 A BE 167935A BE 842969 A BE842969 A BE 842969A
Authority
BE
Belgium
Prior art keywords
thenoylacetic
hypolipidemating
substitute
esters
acids
Prior art date
Application number
BE167935A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE842969A publication Critical patent/BE842969A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/32—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/34—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
BE167935A 1975-06-16 1976-06-15 Acides et esters thenoylacetiques substitues, leur procede de preparation et leur utilisation comme medicaments hypolipidemiants BE842969A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/587,117 US4032647A (en) 1975-06-16 1975-06-16 Substituted thenoylacetic acid and esters

Publications (1)

Publication Number Publication Date
BE842969A true BE842969A (fr) 1976-10-01

Family

ID=24348430

Family Applications (1)

Application Number Title Priority Date Filing Date
BE167935A BE842969A (fr) 1975-06-16 1976-06-15 Acides et esters thenoylacetiques substitues, leur procede de preparation et leur utilisation comme medicaments hypolipidemiants

Country Status (13)

Country Link
US (1) US4032647A (nl)
JP (1) JPS52258A (nl)
AU (1) AU497833B2 (nl)
BE (1) BE842969A (nl)
CA (1) CA1078853A (nl)
DE (1) DE2626385A1 (nl)
ES (1) ES448667A1 (nl)
FR (1) FR2314714A1 (nl)
GB (1) GB1496307A (nl)
NL (1) NL7605837A (nl)
PH (1) PH13873A (nl)
PT (1) PT65104B (nl)
ZA (1) ZA762789B (nl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8525356D0 (en) * 1985-10-15 1985-11-20 Black & Decker Inc Obtaining fixing in wall
US5665874A (en) * 1989-01-17 1997-09-09 John Hopkins University Cancer related antigen
US5759837A (en) * 1989-01-17 1998-06-02 John Hopkins University Chemotherapy for cancer by inhibiting the fatty acid biosynthetic pathway
US5759791A (en) * 1989-01-17 1998-06-02 The Johns Hopkins University Cancer related antigen
US5614551A (en) * 1994-01-24 1997-03-25 The Johns Hopkins University Inhibitors of fatty acid synthesis as antimicrobial agents
US5981575A (en) * 1996-11-15 1999-11-09 Johns Hopkins University, The Inhibition of fatty acid synthase as a means to reduce adipocyte mass

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2126597A1 (de) * 1971-05-28 1972-12-14 Farbwerke Hoechst AG, vormals, Meister Lucius & Brüning, 6000 Frankfurt Aminothiophencarbonsäureester und Verfahren zu ihrer Herstellung
US4000164A (en) * 1973-04-02 1976-12-28 Richardson-Merrell Inc. Hypolipidemic agents

Also Published As

Publication number Publication date
FR2314714A1 (fr) 1977-01-14
PT65104B (en) 1977-09-14
FR2314714B1 (nl) 1978-10-20
DE2626385A1 (de) 1976-12-30
JPS52258A (en) 1977-01-05
AU497833B2 (en) 1979-01-11
PH13873A (en) 1980-10-24
GB1496307A (en) 1977-12-30
NL7605837A (nl) 1976-12-20
CA1078853A (en) 1980-06-03
ZA762789B (en) 1977-04-27
US4032647A (en) 1977-06-28
PT65104A (en) 1976-06-01
ES448667A1 (es) 1977-07-01
AU1368676A (en) 1977-11-10

Similar Documents

Publication Publication Date Title
BE781878A (fr) Nouveaux esters dissymetriques d'acides 1,4-dihydropyridine-dicarboxyliques, leur procede de preparation et leur application comme medicament
FR2283690A1 (fr) Nouveaux composes tetracycliques utiles comme medicaments et leur procede de preparation
FR2289484A1 (fr) Esters d'acides cyclopropanecarboxyliques, leur procede de preparation et leur utilisation notamment comme insecticides
BE770662A (fr) Nouveaux benzylazoles alpha-substitues, leur procede de preparation et leur utilisation comme medicaments
BE848310A (fr) Acides di(phenoxy-2 alcane carboxyliques), leur procede de preparation et leur utilisation comme medicaments
BE858283A (fr) Nouveaux derives de perhydro-aza-heterocycles utiles comme medicaments et procede pour leur preparation
FR2340330A1 (fr) Acides polyvinylbenzenesulfoniques, leur procede de preparation et leur application en tant que medicaments
BE850668A (fr) Nouveaux esters-17 alpha hydroxy-17 alpha de progestatifs utiles comme medicaments et procedes de leur preparation
FR2321884A1 (fr) Nouvelles oxazolidinones-(2), leur procede de preparation et leur application en tant que medicaments
FR2314714A1 (fr) Acides et esters thenoylacetiques substitues, leur procede de preparation et leur utilisation comme medicaments hypolipidemiants
BE765585A (fr) Nouveaux 1-(methyle trisubstitue)-azoles utilisables comme medicaments et leur procede de preparation
FR2278331A1 (fr) Nouveaux acides carboxyliques et leurs derives, leur application comme medicaments et leur procede de preparation
FR2331338A1 (fr) Nouveaux polyenes thienyliques utiles comme medicaments et leur procede de preparation
FR2321293A1 (fr) Nouveaux acides 7b-(d-2-amino-2-(alcoyl inferieur-sulfonylamino-phenyl)- acetylamino)-3-r-3-cephem-4-carboxyliques, leur procede de preparation et leur application en tant que medicaments
FR2298319A1 (fr) Derives du diphenylether utiles comme medicaments et leur procede de preparation
FR2316939A1 (fr) Derives de 2-benzopyranone et leur application comme medicaments
FR2344285A1 (fr) Nouvelles lactones derivees du cyclopentanol, leur procede de preparation et leur application comme medicaments
BE862303A (fr) Nouvelles 0-propyloximes substituees basiquement, leur procede de preparation et leur emploi comme medicaments
BE861137A (fr) Ortho-aminoacetophenones utiles comme medicaments et procede pour leur preparation
BE861337A (fr) Nouveaux derives imidazoliques leur procede de preparation et leur application comme medicaments
BE866588A (fr) Derives de 2-benzyl-perhydroazepines, procede pour leur preparation et application comme medicaments
FR2302733A1 (fr) Nouvelles arylalcoylamines substituees, procede pour leur preparation et leur utilisation comme medicaments
BE814089A (fr) Nouvelles seco-prostaglandines utiles comme medicaments et procede pour leur preparation
BE860615A (fr) 0-(hydroxy-2 propyl) aldoximes substitues basiquement, leur procede de preparation et leur emploi comme medicaments
FR2274302A1 (fr) Nouveaux derives triazoliques utiles comme medicaments et leur procede de preparation